THe challenge
Patients with rare cancers face poor outcomes compared to patients with common cancers. This is because progress requires data and funding, which is traditionally a challenge for rare disease research.
Collaboration = Progress
Revolutionizing Rare Cancer Research through Teamwork and Innovation
Rare Cancer
Isn’t Rare
25% OF CANCER PATIENTS ARE FACING A RARE CANCER
Patients with rare cancers face poor outcomes compared to patients with common cancers. This is because progress requires data and funding, which is traditionally a challenge for rare disease research.
The Broad Institute of MIT & Harvard hosted their 2nd annual Rare Cancer Symposium with this year’s focus on the Rare Cancer Dependency Map Initiative. Read on to learn about the work they are doing and how it is improving the odds of beating rare cancer!
Shortly after an extensive surgery in April of 2012, Katie got a pair of neon sneakers. She chose these glowing shoes because she thought they’d put a smile on people’s faces. Our neon logo reflects Katie’s vibrant love of life and incorporates the classic cancer ribbon into the “K”.